B

Halozyme Therapeutics, Inc. HALO

$95.80 -$0.17-0.18% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

HALO Rating

Reward
Risk

HALO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

HALO Company Overview

Halozyme Therapeutics, Inc. is a U.S.-based biotechnology company focused on developing and commercializing drug delivery technologies and specialty therapeutics. The company operates primarily within the biopharmaceutical and oncology sectors, with its core business centered on its proprietary ENHANZE drug delivery platform, which enables subcutaneous administration of injectable biologics and therapeutics that are traditionally delivered intravenously. Halozyme generates revenue through product sales, licensing agreements, royalties, and collaborative partnerships with large pharmaceutical companies.

The company’s principal revenue drivers include royalties and milestone payments tied to partnered products using the ENHANZE platform, as well as sales from proprietary products. Halozyme serves global pharmaceutical manufacturers, healthcare providers, and patients requiring biologic therapies across oncology, immunology, hematology, and rare disease indications. The company was founded in 1998 and evolved from an early-stage enzyme technology developer into a platform-focused biotechnology company through strategic licensing arrangements and commercialization partnerships with major global drugmakers.

Data compiled by narrative technology. May contain errors.
Sector

HALO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

HALO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

HALO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

HALO Price History

Loading...
52-Week Range48% of range
Current
$95.80
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

HALO Valuation

Market Cap
Market Cap Rank
#2,270
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

HALO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

HALO Corporate Info

Phone Number
858 794 8889
Address
12390 El Camino Real
San Diego, CA 92130
Country
Year Founded

HALO Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 15 and 19 (est)

HALO Headlines